0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Over The Counter (OTC) Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-26R13104
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Over The Counter OTC Drugs Market Research Report 2023
BUY CHAPTERS

Global Over The Counter (OTC) Drugs Market Research Report 2025

Code: QYRE-Auto-26R13104
Report
September 2025
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Over The Counter (OTC) Drugs Market Size

Drugs was valued at US$ 169850 million in the year 2024 and is projected to reach a revised size of US$ 232290 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Over The Counter (OTC) Drugs Market

Over The Counter (OTC) Drugs Market

The global market for Over The Counter (OTC)
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Over The Counter (OTC) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over The Counter (OTC) Drugs.
The Over The Counter (OTC) Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Over The Counter (OTC) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Over The Counter (OTC) Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Over The Counter (OTC) Drugs Market Report

Report Metric Details
Report Name Over The Counter (OTC) Drugs Market
Accounted market size in year US$ 169850 million
Forecasted market size in 2031 US$ 232290 million
CAGR 4.6%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Over The Counter (OTC) Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Over The Counter (OTC) Drugs Market growing?

Ans: The Over The Counter (OTC) Drugs Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Over The Counter (OTC) Drugs Market size in 2031?

Ans: The Over The Counter (OTC) Drugs Market size in 2031 will be US$ 232290 million.

Who are the main players in the Over The Counter (OTC) Drugs Market report?

Ans: The main players in the Over The Counter (OTC) Drugs Market are Bayer AG, Merck KGaA, Novartis, Johnson & Johnson, GlaxoSmithKline, Alkem Laboratories, Teva Pharmaceutical Industries, Pfizer, Sun Pharma, Allergan

What are the Application segmentation covered in the Over The Counter (OTC) Drugs Market report?

Ans: The Applications covered in the Over The Counter (OTC) Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacy, Others

What are the Type segmentation covered in the Over The Counter (OTC) Drugs Market report?

Ans: The Types covered in the Over The Counter (OTC) Drugs Market report are Analgesics, Dermatology Products, Gastrointestinal Products, Vitamins, Mineral, and Supplements (VMS), Weight Loss/Dietary Products, Ophthalmic Products, Sleeping Aids, Others

Recommended Reports

OTC Drug Markets

Pharmaceutical Validation & Compliance

Prescription & Generic Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Analgesics
1.2.3 Dermatology Products
1.2.4 Gastrointestinal Products
1.2.5 Vitamins, Mineral, and Supplements (VMS)
1.2.6 Weight Loss/Dietary Products
1.2.7 Ophthalmic Products
1.2.8 Sleeping Aids
1.2.9 Others
1.3 Market by Application
1.3.1 Global Over The Counter (OTC) Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Over The Counter (OTC) Drugs Market Perspective (2020-2031)
2.2 Global Over The Counter (OTC) Drugs Growth Trends by Region
2.2.1 Global Over The Counter (OTC) Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Over The Counter (OTC) Drugs Historic Market Size by Region (2020-2025)
2.2.3 Over The Counter (OTC) Drugs Forecasted Market Size by Region (2026-2031)
2.3 Over The Counter (OTC) Drugs Market Dynamics
2.3.1 Over The Counter (OTC) Drugs Industry Trends
2.3.2 Over The Counter (OTC) Drugs Market Drivers
2.3.3 Over The Counter (OTC) Drugs Market Challenges
2.3.4 Over The Counter (OTC) Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Over The Counter (OTC) Drugs Players by Revenue
3.1.1 Global Top Over The Counter (OTC) Drugs Players by Revenue (2020-2025)
3.1.2 Global Over The Counter (OTC) Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Over The Counter (OTC) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Over The Counter (OTC) Drugs Revenue
3.4 Global Over The Counter (OTC) Drugs Market Concentration Ratio
3.4.1 Global Over The Counter (OTC) Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Over The Counter (OTC) Drugs Revenue in 2024
3.5 Global Key Players of Over The Counter (OTC) Drugs Head office and Area Served
3.6 Global Key Players of Over The Counter (OTC) Drugs, Product and Application
3.7 Global Key Players of Over The Counter (OTC) Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Over The Counter (OTC) Drugs Breakdown Data by Type
4.1 Global Over The Counter (OTC) Drugs Historic Market Size by Type (2020-2025)
4.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2026-2031)
5 Over The Counter (OTC) Drugs Breakdown Data by Application
5.1 Global Over The Counter (OTC) Drugs Historic Market Size by Application (2020-2025)
5.2 Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Over The Counter (OTC) Drugs Market Size (2020-2031)
6.2 North America Over The Counter (OTC) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Over The Counter (OTC) Drugs Market Size by Country (2020-2025)
6.4 North America Over The Counter (OTC) Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Over The Counter (OTC) Drugs Market Size (2020-2031)
7.2 Europe Over The Counter (OTC) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Over The Counter (OTC) Drugs Market Size by Country (2020-2025)
7.4 Europe Over The Counter (OTC) Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Over The Counter (OTC) Drugs Market Size (2020-2031)
8.2 Asia-Pacific Over The Counter (OTC) Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Over The Counter (OTC) Drugs Market Size (2020-2031)
9.2 Latin America Over The Counter (OTC) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Over The Counter (OTC) Drugs Market Size by Country (2020-2025)
9.4 Latin America Over The Counter (OTC) Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Over The Counter (OTC) Drugs Market Size (2020-2031)
10.2 Middle East & Africa Over The Counter (OTC) Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer AG
11.1.1 Bayer AG Company Details
11.1.2 Bayer AG Business Overview
11.1.3 Bayer AG Over The Counter (OTC) Drugs Introduction
11.1.4 Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.1.5 Bayer AG Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Over The Counter (OTC) Drugs Introduction
11.2.4 Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Over The Counter (OTC) Drugs Introduction
11.3.4 Novartis Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Over The Counter (OTC) Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Over The Counter (OTC) Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.5.5 GlaxoSmithKline Recent Development
11.6 Alkem Laboratories
11.6.1 Alkem Laboratories Company Details
11.6.2 Alkem Laboratories Business Overview
11.6.3 Alkem Laboratories Over The Counter (OTC) Drugs Introduction
11.6.4 Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.6.5 Alkem Laboratories Recent Development
11.7 Teva Pharmaceutical Industries
11.7.1 Teva Pharmaceutical Industries Company Details
11.7.2 Teva Pharmaceutical Industries Business Overview
11.7.3 Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Introduction
11.7.4 Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.7.5 Teva Pharmaceutical Industries Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Over The Counter (OTC) Drugs Introduction
11.8.4 Pfizer Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Sun Pharma
11.9.1 Sun Pharma Company Details
11.9.2 Sun Pharma Business Overview
11.9.3 Sun Pharma Over The Counter (OTC) Drugs Introduction
11.9.4 Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.9.5 Sun Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Details
11.10.2 Allergan Business Overview
11.10.3 Allergan Over The Counter (OTC) Drugs Introduction
11.10.4 Allergan Revenue in Over The Counter (OTC) Drugs Business (2020-2025)
11.10.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Over The Counter (OTC) Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Analgesics
 Table 3. Key Players of Dermatology Products
 Table 4. Key Players of Gastrointestinal Products
 Table 5. Key Players of Vitamins, Mineral, and Supplements (VMS)
 Table 6. Key Players of Weight Loss/Dietary Products
 Table 7. Key Players of Ophthalmic Products
 Table 8. Key Players of Sleeping Aids
 Table 9. Global Over The Counter (OTC) Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Over The Counter (OTC) Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Over The Counter (OTC) Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Over The Counter (OTC) Drugs Market Share by Region (2020-2025)
 Table 13. Global Over The Counter (OTC) Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Over The Counter (OTC) Drugs Market Share by Region (2026-2031)
 Table 15. Over The Counter (OTC) Drugs Market Trends
 Table 16. Over The Counter (OTC) Drugs Market Drivers
 Table 17. Over The Counter (OTC) Drugs Market Challenges
 Table 18. Over The Counter (OTC) Drugs Market Restraints
 Table 19. Global Over The Counter (OTC) Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Over The Counter (OTC) Drugs Market Share by Players (2020-2025)
 Table 21. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2024)
 Table 22. Ranking of Global Top Over The Counter (OTC) Drugs Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Over The Counter (OTC) Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Over The Counter (OTC) Drugs, Headquarters and Area Served
 Table 25. Global Key Players of Over The Counter (OTC) Drugs, Product and Application
 Table 26. Global Key Players of Over The Counter (OTC) Drugs, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Over The Counter (OTC) Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2020-2025)
 Table 30. Global Over The Counter (OTC) Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Over The Counter (OTC) Drugs Revenue Market Share by Type (2026-2031)
 Table 32. Global Over The Counter (OTC) Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2020-2025)
 Table 34. Global Over The Counter (OTC) Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Over The Counter (OTC) Drugs Revenue Market Share by Application (2026-2031)
 Table 36. North America Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Over The Counter (OTC) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Over The Counter (OTC) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Over The Counter (OTC) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Over The Counter (OTC) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Over The Counter (OTC) Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Over The Counter (OTC) Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Over The Counter (OTC) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Over The Counter (OTC) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Over The Counter (OTC) Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Over The Counter (OTC) Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 51. Bayer AG Company Details
 Table 52. Bayer AG Business Overview
 Table 53. Bayer AG Over The Counter (OTC) Drugs Product
 Table 54. Bayer AG Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 55. Bayer AG Recent Development
 Table 56. Merck KGaA Company Details
 Table 57. Merck KGaA Business Overview
 Table 58. Merck KGaA Over The Counter (OTC) Drugs Product
 Table 59. Merck KGaA Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 60. Merck KGaA Recent Development
 Table 61. Novartis Company Details
 Table 62. Novartis Business Overview
 Table 63. Novartis Over The Counter (OTC) Drugs Product
 Table 64. Novartis Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 65. Novartis Recent Development
 Table 66. Johnson & Johnson Company Details
 Table 67. Johnson & Johnson Business Overview
 Table 68. Johnson & Johnson Over The Counter (OTC) Drugs Product
 Table 69. Johnson & Johnson Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 70. Johnson & Johnson Recent Development
 Table 71. GlaxoSmithKline Company Details
 Table 72. GlaxoSmithKline Business Overview
 Table 73. GlaxoSmithKline Over The Counter (OTC) Drugs Product
 Table 74. GlaxoSmithKline Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 75. GlaxoSmithKline Recent Development
 Table 76. Alkem Laboratories Company Details
 Table 77. Alkem Laboratories Business Overview
 Table 78. Alkem Laboratories Over The Counter (OTC) Drugs Product
 Table 79. Alkem Laboratories Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 80. Alkem Laboratories Recent Development
 Table 81. Teva Pharmaceutical Industries Company Details
 Table 82. Teva Pharmaceutical Industries Business Overview
 Table 83. Teva Pharmaceutical Industries Over The Counter (OTC) Drugs Product
 Table 84. Teva Pharmaceutical Industries Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 85. Teva Pharmaceutical Industries Recent Development
 Table 86. Pfizer Company Details
 Table 87. Pfizer Business Overview
 Table 88. Pfizer Over The Counter (OTC) Drugs Product
 Table 89. Pfizer Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 90. Pfizer Recent Development
 Table 91. Sun Pharma Company Details
 Table 92. Sun Pharma Business Overview
 Table 93. Sun Pharma Over The Counter (OTC) Drugs Product
 Table 94. Sun Pharma Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 95. Sun Pharma Recent Development
 Table 96. Allergan Company Details
 Table 97. Allergan Business Overview
 Table 98. Allergan Over The Counter (OTC) Drugs Product
 Table 99. Allergan Revenue in Over The Counter (OTC) Drugs Business (2020-2025) & (US$ Million)
 Table 100. Allergan Recent Development
 Table 101. Research Programs/Design for This Report
 Table 102. Key Data Information from Secondary Sources
 Table 103. Key Data Information from Primary Sources
 Table 104. Authors List of This Report


List of Figures
 Figure 1. Over The Counter (OTC) Drugs Picture
 Figure 2. Global Over The Counter (OTC) Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Over The Counter (OTC) Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Analgesics Features
 Figure 5. Dermatology Products Features
 Figure 6. Gastrointestinal Products Features
 Figure 7. Vitamins, Mineral, and Supplements (VMS) Features
 Figure 8. Weight Loss/Dietary Products Features
 Figure 9. Ophthalmic Products Features
 Figure 10. Sleeping Aids Features
 Figure 11. Others Features
 Figure 12. Global Over The Counter (OTC) Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 13. Global Over The Counter (OTC) Drugs Market Share by Application: 2024 VS 2031
 Figure 14. Hospital Pharmacies Case Studies
 Figure 15. Retail Pharmacies Case Studies
 Figure 16. Online Pharmacy Case Studies
 Figure 17. Others Case Studies
 Figure 18. Over The Counter (OTC) Drugs Report Years Considered
 Figure 19. Global Over The Counter (OTC) Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Over The Counter (OTC) Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Over The Counter (OTC) Drugs Market Share by Region: 2024 VS 2031
 Figure 22. Global Over The Counter (OTC) Drugs Market Share by Players in 2024
 Figure 23. Global Top Over The Counter (OTC) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over The Counter (OTC) Drugs as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Over The Counter (OTC) Drugs Revenue in 2024
 Figure 25. North America Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Over The Counter (OTC) Drugs Market Share by Country (2020-2031)
 Figure 27. United States Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Over The Counter (OTC) Drugs Market Share by Country (2020-2031)
 Figure 31. Germany Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Over The Counter (OTC) Drugs Market Share by Region (2020-2031)
 Figure 39. China Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Over The Counter (OTC) Drugs Market Share by Country (2020-2031)
 Figure 47. Mexico Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Over The Counter (OTC) Drugs Market Share by Country (2020-2031)
 Figure 51. Turkey Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Over The Counter (OTC) Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. Bayer AG Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 55. Merck KGaA Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 56. Novartis Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 57. Johnson & Johnson Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 58. GlaxoSmithKline Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 59. Alkem Laboratories Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 60. Teva Pharmaceutical Industries Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 61. Pfizer Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 62. Sun Pharma Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 63. Allergan Revenue Growth Rate in Over The Counter (OTC) Drugs Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS